Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2024-11-27 00:00:00 ET · period of report 2024-11-25 · accession 0001873919-24-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-27 | 2024-11-25 | CADL | Aguilar Laura K. | 10% | D - Sale to Iss | $4.97 | -20.0K | 151.3K | -12% | -$99.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | CADL | 2024-11-25 | D | D | 20,000 | $4.97 | 151,335 | D | — | — | (F1) Shares of common stock held jointly with spouse |